Urticaria- bane or boon to treat with omalizumab? A case series

Authors

  • Sowmya Arudi Nagarajan
  • Harsha NS
  • Nagashree V Sharma

DOI:

https://doi.org/10.32677/IJCR.2019.v05.i04.001

Keywords:

Antihistamines, Anti-IgE, Monoclonal antibody, Omalizumab, Urticaria.

Abstract

Chronic spontaneous urticaria (CSU) is a condition characterised by the presence of hives with/without angioedema that affects individuals on more days than not for 6 weeks or more. This can be a very debilitating condition affecting the quality of life. Here, we report 3 cases of severe prolonged chronic spontaneous urticaria in 7-year-old, 20-year-old and 25-year-old individuals that went into rapid remission following the treatment with Omalizumab, anti-IgE monoclonal antibody.

Downloads

Download data is not yet available.

Downloads

Published

2019-08-26

Issue

Section

Case Series

How to Cite

Urticaria- bane or boon to treat with omalizumab? A case series. (2019). Indian Journal of Case Reports, 5(4), 305-307. https://doi.org/10.32677/IJCR.2019.v05.i04.001

Most read articles by the same author(s)

<< < 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 > >>